This is consistent with Soblechero et al. that reported a case of neonatal hypercalcemia due to a homozygous deletion/frameshift mutation in the CaSR in which there was therapeutic failure of Cinacalcet [1]. The gene discussed is CASR; the disease is Hypercalcemia.